Metal(II) complexes of bioactive aminonaphthoquinone-based ligand: synthesis,characterization and BSA binding,DNA binding/cleavage,and cytotoxicity studies

An aminonaphthoquinone ligand, L, and its metal complexes of general formula [MLCl₂] {M = Co(II), Ni(II), Cu(II) and Zn(II)} have been synthesized and characterized by analytical and spectral techniques. Tetrahedral geometry has been assigned to Ni(II) and Zn(II) complexes and square planar geometry to Co(II) and Cu(II) complexes on the basis of electronic spectral and magnetic susceptibility data. The binding of complexes with bovine serum albumin (BSA) is relatively stronger than that of free ligand and alters the conformation of the protein molecule. Interaction of these complexes with CT-DNA has been investigated using UV-Vis and fluorescence quenching experiments, which show that the complexes bind strongly to DNA through intercalative mode of binding (K_app 10⁵ M^?1). Molecular docking studies reiterate the mode of binding of these compounds with DNA, proposed by spectral studies. The ligand and its complexes cleave plasmid DNA pUC18 to nicked (Form II) and linear (Form III) forms in the presence of H₂O₂ oxidant. The in vitro cytotoxicity screening shows that Cu(II) complex is more potent against MCF-7 cells and Zn(II) complex exhibits marked cytotoxicity against A-549 cells equal to that of cisplatin. Cell imaging studies suggested apoptosis mode of cell death in these two chosen cell lines.     

Novel asymmetric 3,5‐bis(arylidene)piperidin‐4‐one derivatives: synthesis,crystal structures and cytotoxicity

3,5‐Bis(arylidene)piperidin‐4‐one derivatives (BAPs) display good antitumour activity because of their double α,β‐unsaturated ketone structural characteristics. Reported BAPs have generally been symmetric and asymmetric BAPs have been little documented. Three asymmetric BAPs, namely (5E)‐3‐(4‐tert‐butylbenzylidene)‐5‐(4‐fluorobenzylidene)‐1‐methylpiperidin‐4‐one, C₂₄H₂₆FNO, ( 5 ), (5E)‐3‐(4‐tert‐butylbenzylidene)‐5‐(3,5‐dimethoxybenzylidene)‐1‐methylpiperidin‐4‐one, C₂₆H₃₁NO₃, ( 6 ), and (5E)‐3‐{3‐[(E)‐(2,3‐dihydroxybenzylidene)amino]benzylidene}‐5‐(2‐fluorobenzylidene)‐1‐methylpiperidin‐4‐one, C₂₇H₂₃FN₂O₃, ( 12 ), were generated by Claisen–Schmidt condensation. They are characterized by NMR and FT–IR spectroscopies, and elemental analysis. Single‐crystal structure analysis reveals that the two arylidene rings on both sides of the BAP structures adopt an E stereochemistry of the olefinic double bonds and the compounds are E,E isomers. Molecules of ( 5 ) and ( 12 ) generate one‐dimensional chains through intermolecular hydrogen bonds, while compound ( 6 ) generates a two‐dimensional network through hydrogen bonds. Preliminary cytotoxicities toward human liver hepatocellular carcinoma cell line (HepG2), human acute mononuclear granulocyte leukaemia (THP‐1) and human normal hepatical cell line (LO2) were evaluated.     

Synthesis,characterization, DNA binding,DNA cleavage,antioxidant and in vitro cytotoxicity studies of ruthenium(II) complexes containing hydrazone ligands

The synthesis, spectral characterization, and biological studies of ruthenium(II) hydrazone complexes [RuCl(CO)(PPh₃)₂L] (where L = hydrazone ligands) have been carried out. The hydrazones are monobasic bidentate ligands with O and N as the donors and are preferably found in the enol form in all the complexes. The molecular structure of the ligands HL¹, HL²_, and HL³ were determined by single-crystal X-ray diffraction. The DNA binding studies of the ligands and complexes were carried out by absorption spectroscopic and viscosity measurements. The results revealed that the ligands and complexes bind to DNA via intercalation. The DNA cleavage activity of the complexes, evaluated by gel electrophoresis assay, revealed that the complexes are good DNA cleaving agents. The antioxidant properties of the complexes were evaluated against DPPH, OH, and NO radicals, which showed that the complexes have strong radical-scavenging. Further, the in vitro cytotoxic effect of the complexes examined on HeLa and MCF-7 cancer cell lines showed that the complexes exhibited significant anticancer activity.     

Biological evaluation of organometallic palladium(II) complexes containing 4‐hydroxybenzoic acid (3‐ethoxy‐2‐hydroxybenzylidene)hydrazide: Synthesis,structure, DNA/protein binding,antioxidant activity and cytotoxicity

New palladium(II) complexes, [Pd(PPh₃)L] ( 2 ) and [Pd(AsPh₃)L] ( 3 ), were synthesized using 4‐hydroxybenzoic acid (3‐ethoxy‐2‐hydroxybenzylidene)hydrazide ( 1 ) ligand (H₂L), and characterized using various physicochemical techniques. The molecular structures of 2 and 3 were determined using single‐crystal X‐ray diffraction, which reveals a square planar geometry around the palladium(II) metal ion. In vitro DNA binding studies were conducted using UV–visible absorption spectroscopy, emission spectroscopy, cyclic voltammetry and viscosity measurements, which suggest that the metal complexes act as efficient DNA binders. The interaction of ligand H₂L and complexes 2 and 3 with bovine serum albumin (BSA) was investigated using UV–visible and fluorescence spectroscopies. Absorption and emission spectral studies indicate that complexes 2 and 3 interact with BSA protein more strongly than the parent ligand. The free radical scavenging potential of all the synthesised compounds ( 1 – 3 ) was also investigated under in vitro conditions. In addition, the in vitro cytotoxicity of the complexes to tumour cells lines (HeLa and MCF‐7) was examined using the MTT assay method.     

Two novel benzenedicarboxylate‐metal complexes: synthesis,crystal structures and fluorescent properties

Two novel benzenedicarboxylate–metal complexes, [Sm(nphth)(Hnphth)(H₂O)₃^?H₂O]₂ and [Zn(nphth)(bipy)(H₂O) ?H₂O]₂ (2) (H₂nphth = 3‐nitrophthalic acid, bipy = 2,2′‐bipyridine), have been synthesized under hydrothermal condition and characterized by single‐crystal X‐ray diffraction. Both complex 1 and 2 exhibit a dimeric structure, and nphth ligand shows different coordination mode in the f‐block and d‐block complexes. The fluorescent properties of two complexes are investigated; the results reveal that the two complexes show different kinds of fluorescence. Copyright © 2007 John Wiley & Sons, Ltd.     

Phosphoester binding,DNA binding,DNA cleavage and in vitro cytotoxicity studies of simple heteroleptic copper(II) complexes with bidentate ligands

Abstract

Two mononuclear heteroleptic copper complexes, [Cu(±trans-dach)(bpy)](ClO₄)₂ 1a and [Cu(±trans-dach)(phen)](ClO₄)₂ 2a [dach?=?1,2-diaminocyclohexane, bpy?=?2,2′-bipyridine and phen?=?1,10-phenanthroline], were synthesized and analyzed by CHN analysis, electronic absorption, FT-IR spectroscopy, EPR, and SXRD. The molecular structures of 1a and 2a showed octahedral geometry around Cu(II). Both complexes interacted with phosphoesters and DNA. Their binding affinities with diphenylphosphate, di n-butylphosphate, trimethylphosphate, and triphenylphosphate were studied by UV–vis spectroscopy. For understanding the stereochemical role of dach ligand toward DNA interaction, enantiopure DACH complexes [Cu(R,R-trans-dach(bpy)](ClO₄)₂ 1b, [Cu(S,S-trans-dach)(bpy)](ClO₄)₂ 1c, [Cu(cis-dach)(bpy)](ClO₄)₂ 1d, [Cu(R,R-trans-dach)(phen)](ClO₄)₂ 2b, [Cu(S,S-trans-dach)(phen)](ClO₄)₂ 2c, and [Cu(cis-dach)(phen)](ClO₄)₂ 2d were synthesized and analyzed. All complexes interacted with calf thymus-DNA (CT-DNA) as studied by UV–vis spectroscopy. The nature of binding to CT-DNA was groove/electrostatic as supported by circular dichroism, cyclic voltammetry, and docking studies. Complexes were able to cleave plasmid DNA at 12.5 µM (1a–d) and 6 µM (2a–d), where 2d showed 64% Form II and 36% Form III. The in vitro cytotoxic studies of two different cancer cell lines showed inhibition with low IC₅₀ value in comparison to reference control (cisplatin). These complexes are efficient in inducing apoptosis in cancer cells, making them viable for potent anticancer activity.     

Studies on the manganese and copper complexes derived from chiral Schiff base: synthesis,structure, cytotoxicity and DNA/BSA interaction

Abstract

Three new manganese and copper complexes, [Mn(ONO-(S)L¹)₂] (1), [Cu(ONO-(R)L²)]₄·2CH₃OH (2), and [Mn₃(ONO-(S)L³)₄(OAc)₄(H₂O)₂] (3), {[H₂L¹ = (S)-2-phenyl-2-(2-hydroxy-5-chlorobenzylideneamino)ethane-1-ol], H₂L² = (R)-2-(2-hydroxy-5-chlorobenzylideneamino)butane-1-ol] and H₂L³ = (S)-2-phenyl-2-(2-hydroxy-3-methoxybenzylideneamino)ethane-1-ol]}, have been synthesized. The crystal structures of 1–3 were determined through single-crystal X-ray diffraction. The structure of mononuclear 1 shows a six-coordinate octahedral geometry around the manganese ion. Complex 2 is a five-coordinate tetranuclear copper complex with the central Cu atoms adopting distorted square pyramidal geometry. Complex 3 shows a trinuclear structure with the six-coordinate Mn ions surrounded by four L³ ligands and acetate ions. The in vitro cytotoxicity screening revealed that the 1–3 had substantial cytotoxicity against three cancer cell lines (HepG2, MDA-MB-231, and A549), even higher than that of cisplatin. Inspiringly, 2 derived from (R)-Schiff base ligand H₂L² was more potent against MDA-MB-231 cells. Interaction of 1–3 with calf-thymus DNA (CT-DNA) has been investigated using UV-vis, viscosity and thermal denaturation experiments. It was found that 1 binds with DNA through intercalation while 2 and 3 interact with DNA probably through groove-binding and electrostatic mode. In addition, the capability of the complexes to bind with bovine serum albumin was monitored using some spectral techniques. The metal ions, chiral and nuclearity have significant influences on the properties of the title compounds.     

A novel three‐dimensional SrII coordination polymer based on benzene‐1,2,4,5‐tetracarboxylate: hydrothermal synthesis,crystal structure and spectroscopic and thermal studies

Coordination of the anions of benzenecarboxylic acids with metal cations leads to coordination polymers with various structural features. Very few examples of strontium‐based structures have been reported. A new three‐dimensional coordination polymer, namely poly[aqua(μ₁₂‐benzene‐1,2,4,5‐tetracarboxylato)distrontium(II)], [Sr₂(C₁₀H₂O₈)(H₂O)]_n , has been synthesized under hydrothermal conditions and characterized by thermal analysis, vibrational spectroscopy (Raman and IR), single‐crystal X‐ray diffraction and powder X‐ray diffraction. The coordination geometries around the two independent Sr^II ions can be described as a distorted dodecahedron and a distorted monocapped square antiprism. The compound features a three‐dimensional structure containing inorganic motifs, with two‐dimensional layers connected through organic linkers, and possesses a topologic structure of a binodal (6,12) connected alb net with the Schläfli symbol {4¹⁵}₂{4⁴⁸.6¹⁸}. The final product of thermal decomposition is strontium oxide (SrO).     

A half‐sandwich TaV dichlorido complex containing an O,N,O′‐tridentate Schiff base ligand: synthesis,crystal structure and in vitro cytotoxicity

A new electroneutral half‐sandwich tantalum(V) dichlorido complex containing pentamethylcyclopentadienyl (Cp*) and the double‐deprotonated version of the Schiff base 2‐ethoxy‐6‐{(E)‐[(2‐hydroxyphenyl)imino]methyl}phenol (H₂L) as ligands, namely cis‐dichlorido(2‐ethoxy‐6‐{(E)‐[(2‐oxidophenyl)imino]methyl}phenolato‐κ³O,N,O′)(η⁵‐pentamethylcyclopentadienyl)tantalum(V), [Ta(C₁₀H₁₅)(C₁₅H₁₃NO₃)Cl₂] or [Ta(η⁵‐Cp*)(L)Cl₂], has been prepared and thoroughly characterized by elemental analysis, IR and NMR spectroscopy, mass spectrometry, density functional theory (DFT) calculations and single‐crystal X‐ray diffraction. The molecular structure revealed that the Ta^V centre is coordinated by a η⁵‐Cp* ligand, two monodentate chlorido ligands and one O,N,O′‐tridentate L^2? ligand. The crystal structure is stabilized by C—H…C, C—H…Cl and C…C intermolecular interactions. Moreover, the complex shows notable in vitro cytotoxicity against the A2780 human ovarian carcinoma cell line, with IC₅₀ = 14.4 µM, which is higher than that of the conventional platinum‐based anticancer drug cisplatin (IC₅₀ = 20.1 µM).     

Dinuclear cadmium indomethacin and Lawsone complexes: synthesis,crystal structures,antiproliferative and biological evaluations

The synthesis and structural characterizations of Cd(II) indomethacin (Indo) and Lawsone (Law) complexes, K₂[Cd₂(Indo)₄(SCN)₂], 1 and [Cd₂(Law)₄(phen)₂]·4CH₃OH, 2 (SCN = thiocyanate, phen = 1,10-phenanthroline), have been studied. The complexes are dimeric, structurally characterized by spectral (IR, TOF-Mass) and X-ray crystallography. The interaction of indomethacin and Lawsone ligands, 1 and 2 with calf thymus DNA and bovine serum albumin were investigated using UV–visible and fluorescence spectrophotometric methods. The in vitro cytotoxicity of 1 and 2 was examined against promyelocytic leukemia (HL-60), colon (HCT-8), brain (SF-295), and melanoma (MDA-MB-435) cancer cell lines. Moreover, the antimicrobial activity of 1 and 2 against different strains of pathogenic bacteria were tested.     

Two silver(I) complexes with bis(benzimidazole)‐2‐oxopropane ligands: Syntheses,crystal structures and DNA binding studies

Two Ag(I) complexes, [Ag₂(bobb)₂]⋅(NO₃)₂ ( 1 ) and [Ag₂(crotonate)₂(aobb)]_n ( 2 ) (bobb =1,3‐bis(1‐benzylbenzimidazol‐2‐yl)‐2‐oxapropane; aobb =1,3‐bis(1‐allylbenzimidazol‐2‐yl)‐2‐oxopropane), have been synthesized and characterized using elemental analysis, electrical conductivities, infrared and UV–visible spectral measurements and single‐crystal X‐ray diffraction. Complex 1 is binuclear and three‐coordinated by two N atoms from two bobb ligands, while complex 2 is a unique metal organic compound with diamond‐like multinuclear Ag centers with each Ag bridged by two aobb ligands and two crotonate ions to form one‐dimensional single polymer chain structures and extended into two‐dimensional frameworks through π–π and intermolecular C─H⋅⋅⋅O hydrogen bonds. The adjacent Ag(I) centers are bridged by allyl from aobb which is not only a σ‐bonding ligand, but also a π‐acid ligand. The DNA binding modes of complexes 1 and 2 were investigated using electronic absorption titration, fluorescence spectra and viscosity measurements. The results suggest that the two complexes bind to DNA via an intercalative mode, and their binding affinity for DNA follows the order 2  >  1 . This is due to the chelating effects which can enhance the planar functionality of the metal complexes.     

Synthesis,characterization and in vitro biological assays of copper(II) and nickel(II) complexes with furan‐­2­‐carboxylic acid hydrazide

Two transition metal complexes, [Cu(FH)₃]⋅2Cl⋅2H₂O and [Ni(FH)₃]⋅2Cl⋅2H₂O, were synthesized from the reactions of furan‐2‐carboxylic acid hydrazide with CuCl₂⋅2H₂O and NiCl₂⋅6H₂O. The synthesized complexes were characterized using analytical and various spectral techniques. The structures of the complexes were determined using single‐crystal X‐ray diffraction. The interactions of the complexes with calf thymus DNA (CT‐DNA) were studied using absorption, fluorescence, cyclic voltammetric and viscosity measurements. The experimental results showed that the complexes could interact with CT‐DNA through intercalation. A gel electrophoresis assay demonstrated the ability of the complexes to cleave pBR322 DNA. The binding interaction of the complexes with bovine serum albumin was investigated using a fluorescence spectroscopic method. The radical scavenging ability, assessed using a series of antioxidant assays involving 2,2‐diphenyl‐2‐picrylhydrazyl radical, hydroxyl radical and nitric oxide radical, showed that the complexes possess significant radical scavenging properties. Further, the in vitro cytotoxic effect of the complexes examined on cancerous cell lines, such as human cervical cancer cells (HeLa) and human breast cancer cell line (MCF‐7), showed that the complexes exhibit significant anticancer activity.     

High‐pressure synthesis and crystal structure of the strontium tungstate Sr3W2O9

The strontium tungstate compound Sr₃W₂O₉ was prepared by a high‐pressure synthesis technique. The crystal structure was determined by single‐crystal X‐ray diffraction and transmission electron microscopy. The structure was found to be a hettotype structure of the high‐pressure phase of Ba₃W₂O₉, which has corner‐sharing octahedra with a trigonal symmetry. Sr₃W₂O₉ has a monoclinic unit cell of C2/c symmetry. One characteristic of the structure is the breaking of the threefold rotation symmetry existing in the high‐pressure phase of Ba₃W₂O₉. The substitution of Sr at the Ba site results in a significant shortening of the interlayer distances of the [AO₃] layers (A = Ba, Sr) and causes a distortion in the crystal structure. In Sr₃W₂O₉, there is an off‐centre displacement of W⁶⁺ ions in the WO₆ octahedra. Such a displacement is also observed in the high‐pressure phase of Ba₃W₂O₉.     

Ruthenium(II) bipyridine complexes: from synthesis and crystal structures to electrochemical and cytotoxicity investigation

Complexes 1–4, [Ru(L)(bpy)₂]PF₆, where bpy = 2,2′-bipyridine; HL = 3-methylpyridine-2-carboxylic acid (HL1), 6-methylpyridine-2-carboxylic acid (HL2), 5-bromopyridine-2-carboxylic acid (HL3) and 6-bromopyridine-2-carboxylic acid (HL4), were synthesized and characterized. The electrochemical character of the complexes was investigated by cyclic voltammetry revealing two reversible reduction waves in the negative range of potentials, most likely due to a reduction of the bipyridine moiety. Cytotoxicity studies by MTT assay for 72 h of drug action revealed that 2–4 exhibited moderate activity in cervical human tumor cells (HeLa). Complex 2 exhibited low activity in colon cancer LS-174 cells (180 ± 10), while all complexes were devoid of activity in lung cancer A549 and non-tumor MRC-5 cells, up to 200 μM. Combinational studies of the most active complex 2, with pharmacological modulators of cell redox status, L-buthionine-sulfoximine (L-BSO) or N-acetyl-L-cysteine (NAC), showed that when L-BSO potentiated, 2 induced a sub-G1 peak of the cell cycle in the HeLa cell line. UV–vis and cyclic voltammetry were performed in order to investigate the binding mode of 2 to DNA and suggested intercalation for the complex–DNA interaction.     

Synthesis,crystal structure,DNA/bovine serum albumin binding and antitumor activity of two transition metal complexes with 4‐acylpyrazolone derivative

Two new complexes, namely [Cu₆L₆] ( 1 ) and [Zn(HL)₂] ( 2 ) (H₂L = N‐(1‐phenyl‐3‐methyl‐4‐propenylidene‐5‐pyrazolone)‐2‐furancarboxylic acid hydrazide), have been synthesized and characterized. Single crystal X‐ray analysis indicates that complex 1 has a hexanuclear structure and complex 2 exhibits a mononuclear structure. The DNA/bovine serum albumin (BSA) binding properties of complexes 1 and 2 were investigated by absorption spectroscopy and fluorescence quenching. Both complexes could effectively intercalate to DNA with calculated quenching constants of 2.6 × 10⁵ and 1.25 × 10⁵ M^?1, respectively. The quenching mechanism of the intrinsic fluorescence of BSA by the complexes was found to be a static one. The cytotoxicities of 1 and 2 were investigated in two human tumor cell lines, human esophageal cancer cells (Eca‐109) and cervical cancer cells (HeLa). Complex 1 exhibits higher antitumor activity than 2 . Furthermore, 1 can inhibit HeLa cells by inducing apoptosis and G0/G1 phase cell cycle arrest. All results demonstrate that 1 and 2 both have DNA/BSA binding capacity and antitumor activity.     

Synthesis,characterization and in vitro DNA binding studies of a new copper(II) complex containing antioxidant ferulic acid

A mononuclear Cu(II) complex, [Cu(FA)₂(NO₃)₂], in which FA is ferulic acid ((E)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enoic acid), was synthesized and characterized by spectroscopic methods. The main structures of the ligand and its complexes with Cu²⁺ were optimized by QM calculations. The calculations on the structures of the [Cu(FA)₂(NO₃)₂] complexes forms and the intercalating with DNA profile were undertaken by UHF/PM6 and MMFF94 methods, respectively. In vitro studies (UV-vis spectroscopy, emission titration, circular dichroism techniques, and viscometry) under physiological conditions (Tris-HCl buffer solutions, pH 7.4) showed that the complex interacts with calf-thymus DNA (ct-DNA) via an intercalative binding mode. The thermodynamic parameters, enthalpy change (ΔH), and entropy change (ΔS) showed that the acting forces between Cu(II) complex and ct-DNA mainly included van der Waals interactions and hydrogen bonds. Methylene blue (MB) displacement studies revealed that Cu(II) complex can substitute MB probe in the MB-DNA complex which was indicative of intercalative binding. The theoretical data confirm the experimental results with respect to the mechanism of binding.     

p‐Toluate‐bridged dinuclear Cu(II) complexes in combination with tridentate chelating ligand: Crystal structure,density functional theory calculation,DNA/protein binding and catecholase activity

The dinuclear Cu(II) complexes [Cu₂(L¹)₂(mb)]?ClO₄ ( 1 ) and [Cu₂(L²)₂(mb)]?ClO₄ ( 2 ) (HL¹ = 2‐[(2‐diethylaminoethylimino)methyl]phenol; HL² = 2‐[1‐(2‐diethylaminoethylimino)propyl]phenol; mb = 4‐methylbenzoate) were synthesized and characterized using X‐ray crystal structure analysis and spectroscopic methods. Complexes 1 and 2 are dinuclear with distorted square pyramidal Cu (II) geometries, where Schiff base coordinates with tridentate (N,N,O) chelating mode and mb bridges two metal centres. Optimized structures and photophysical properties of ligands and complexes were calculated using density functional theory and time‐dependent density functional theory methods using B3LYP functional with 6‐31G (d,p) and LanL2MB basis sets. Interactions of the complexes with bovine serum albumin (BSA) and human serum albumin (HSA) were studied using UV–visible absorption and fluorescence spectroscopies and the calculated values of association constants (M^?1) are 1.7 × 10⁵ ( 1 –BSA), 5.7 × 10⁵ ( 2 –BSA), 1.6 × 10⁵ ( 1 –HSA) and 6.9 × 10⁵ ( 2 –HSA). Interactions of the complexes with calf thymus DNA were also investigated and the binding affinities are 1.4 × 10⁵ and 1.6 × 10⁵ M^?1 for 1 and 2 , respectively. Both complexes catalytically oxidize 3,5‐di‐tert‐butylcatechol to 3,5‐di‐tert‐butylbenzoquinone in the presence of molecular oxygen.     

Synthesis,structure and in vitro cytotoxicity testing of some 1,3,4‐oxadiazoline derivatives from 2‐hydroxy‐5‐iodobenzoic acid

The syntheses of nine new 5‐iodosalicylic acid‐based 1,3,4‐oxadiazoline derivatives starting from methyl salicylate are described. These compounds are 2‐[4‐acetyl‐5‐methyl‐5‐(3‐nitrophenyl)‐4,5‐dihydro‐1,3,4‐oxadiazol‐2‐yl]‐4‐iodophenyl acetate ( 6a ), 2‐[4‐acetyl‐5‐methyl‐5‐(4‐nitrophenyl)‐4,5‐dihydro‐1,3,4‐oxadiazol‐2‐yl]‐4‐iodophenyl acetate ( 6b ), 2‐(4‐acetyl‐5‐methyl‐5‐phenyl‐4,5‐dihydro‐1,3,4‐oxadiazol‐2‐yl)‐4‐iodophenyl acetate, C₁₉H₁₇IN₂O₄ ( 6c ), 2‐[4‐acetyl‐5‐(4‐fluorophenyl)‐5‐methyl‐4,5‐dihydro‐1,3,4‐oxadiazol‐2‐yl]‐4‐iodophenyl acetate, C₁₉H₁₆FIN₂O₄ ( 6d ), 2‐[4‐acetyl‐5‐(4‐chlorophenyl)‐5‐methyl‐4,5‐dihydro‐1,3,4‐oxadiazol‐2‐yl]‐4‐iodophenyl acetate, C₁₉H₁₆ClIN₂O₄ ( 6e ), 2‐[4‐acetyl‐5‐(3‐bromophenyl)‐5‐methyl‐4,5‐dihydro‐1,3,4‐oxadiazol‐2‐yl]‐4‐iodophenyl acetate ( 6f ), 2‐[4‐acetyl‐5‐(4‐bromophenyl)‐5‐methyl‐4,5‐dihydro‐1,3,4‐oxadiazol‐2‐yl]‐4‐iodophenyl acetate ( 6g ), 2‐[4‐acetyl‐5‐methyl‐5‐(4‐methylphenyl)‐4,5‐dihydro‐1,3,4‐oxadiazol‐2‐yl]‐4‐iodophenyl acetate ( 6h ) and 2‐[5‐(4‐acetamidophenyl)‐4‐acetyl‐5‐methyl‐4,5‐dihydro‐1,3,4‐oxadiazol‐2‐yl]‐4‐iodophenyl acetate ( 6i ). The compounds were characterized by mass, ¹H NMR and ¹³C NMR spectroscopies. Single‐crystal X‐ray diffraction studies were also carried out for 6c , 6d and 6e . Compounds 6c and 6d are isomorphous, with the 1,3,4‐oxadiazoline ring having an envelope conformation, where the disubstituted C atom is the flap. The packing is determined by C—H…O, C—H…π and I…π interactions. For 6e , the 1,3,4‐oxadiazoline ring is almost planar. In the packing, Cl…π interactions are observed, while the I atom is not involved in short interactions. Compounds 6d , 6e , 6f and 6h show good inhibiting abilities on the human cancer cell lines KB and Hep‐G2, with IC₅₀ values of 0.9–4.5 µM.     

Low-dimensional compounds containing bioactive ligands. XXII. First crystal structure,cytotoxic activity and DNA and HSA binding of a zirconium(IV) complex with 8-hydroxyquinoline-2-carboxylic acid

A new zirconium(IV) complex, diaquabis(8-hydroxyquinoline-2-carboxylato-κ³N,O²,O⁸)zirconium(IV) dimethylformamide disolvate, [Zr(C₁₀H₅NO₃)₂(H₂O)₂]·2C₃H₇NO or [Zr(QCa)₂(H₂O)₂]·2DMF ( 1 ) (HQCaH is 8-hydroxyquinoline-2-carboxylic acid and DMF is dimethylformamide), was prepared and characterized by elemental analysis, IR spectroscopy and single-crystal X-ray structure analysis. Complex 1 is a mononuclear complex in which the Zr^IV atoms sit on the twofold axis and they are octacoordinated by two N and six O atoms of two tridentate anionic QCa²⁻ ligands, and two aqua ligands. Outside the coordination sphere are two DMF molecules bound to the complex unit by hydrogen bonds. The structure and stability of complex 1 in dimethyl sulfoxide were verified by NMR spectroscopy. The cytotoxic properties of 1 and HQCaH were studied in vitro against eight cancer cell lines, and their selectivity was tested on the BJ-5ta noncancerous cell line. Both the complex and HQCaH exhibited low activity, with IC₅₀ > 200 µM. DNA and human serum albumin (HSA) binding studies showed that 1 binds to calf thymus (CT) DNA via intercalation and is able to bind to the tryptophan binding site of HSA (Trp-214).     

Heteroscorpionate‐based heteroleptic copper(II) complexes: Antioxidant,molecular docking and in vitro cytotoxicity studies

Three new heteroscorpionate ligands, (2‐hydroxyphenyl)bis(imidazol‐1‐yl)methane (HL¹), (4‐diethylamino‐2‐hydroxyphenyl)bis(imidazol‐1‐yl)methane (HL²) and (5‐bromo‐2‐hydroxyphenyl)bis(imidazol‐1‐yl)methane (HL³), and their heteroleptic copper(II) complexes of the type [Cu(L^1–3)diimine]ClO₄ ( 1 – 6 ; where diimine =2,2′‐bipyridyl or 1,10‐phenanthroline) have been synthesized and characterized using spectroscopic methods. The molecular structure of ligand HL¹ was determined by single‐crystal X‐ray diffraction. UV–visible, electron paramagnetic resonance and theoretical studies suggest a distorted square pyramidal geometry around copper(II) ion. Analyses of highest occupied and lowest unoccupied molecular orbitals have been used to explain the charge transfer taking place within the complexes. The antioxidant activities of the heteroscorpionate ligands and their heteroleptic copper(II) complexes were determined using ABTS, DPPH and H₂O₂ free radical scavenging assays with respect to standard antioxidant ascorbic acid. In molecular docking studies, the complexes showed π–π, hydrogen bonding, van der Waals and electrostatic interactions with fibroblast growth factor receptor kinase. In vitro cytotoxicity activities of ligands and copper(II) complexes were examined on human breast adenocarcinoma (MCF‐7), cervical (HeLa) and lung (A549) cancer cell lines and normal human dermal fibroblast cell line using MTT assay. Complex 4 exhibited higher anticancer activity than the other complexes against all three cancer lines, being more potent than the standard drug cisplatin.